Ligand · CI9
CI9 · N-({(1S)-5-[4-(13-{[2,4-bis(dihydroxyamino)phenyl]amino}-2,5,8,11-tetraoxatridec-1-yl)-1H-1,2,3-triazol-1-yl]-1-carboxypentyl}carbamoyl)-L-glutamic acid
CI9, N-({(1S)-5-[4-(13-{[2,4-bis(dihydroxyamino)phenyl]amino}-2,5,8,11-tetraoxatridec-1-yl)-1H-1,2,3-triazol-1-yl]-1-carboxypentyl}carbamoyl)-L-glutamic acid (C29 H46 N8 O15, 746.7 g/mol), in the MolNFT structures on GenesisL1: bound in 2…
- Component
- CI9
- Formula
- C29 H46 N8 O15
- Class
- ligand
- Structures
- 2
- PDB entries
- 1
Binding sites
CI9 in 2 structures; the first of them:
- 2XEG · Human glutamate carboxypeptidase II in complex with Antibody- Recruiting Molecule ARM-P4 · CI9 A1768 · binds LYS207, VAL208, PHE209, ARG210, GLY256, ASN257, ASP387, GLU424 and 25 more
- 2XEG · Human glutamate carboxypeptidase II in complex with antibody- recruiting molecule arm-P4 · CI9 A1768 · binds LYS207, VAL208, PHE209, ARG210, GLY256, ASN257, ASP387, GLU424 and 25 more
Residues it binds most
ARG 2, GLY 2, ASN 2, ASP 2, GLU 2, SER 2, LYS 2, THR 2, TYR 2, ALA 2 (residue and the binding sites it lines).
Found with
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.